"hepatocellular carcinoma patients" trang 5 - tải miễn phí từ tailieunhanh
Distant survival for patients undergoing surgery using volatile versus IV anesthesia for hepatocellular carcinoma with portal vein tumor thrombus: A retrospective study

Distant survival for patients undergoing surgery using volatile versus IV anesthesia for hepatocellular carcinoma with portal vein tumor thrombus: A retrospective study
10    21    1
Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation

Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation
14    18    1
The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: Basing on competing risk model

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: Basing on competing risk model
9    15    1
Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: A systematic review and critical appraisal

Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: A systematic review and critical appraisal
17    22    1
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial

Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial
10    14    1
Stereotactic body radiation therapy as a salvage treatment for single viable hepatocellular carcinoma at the site of incomplete transarterial chemoembolization: A retrospective analysis of 302 patients

Stereotactic body radiation therapy as a salvage treatment for single viable hepatocellular carcinoma at the site of incomplete transarterial chemoembolization: A retrospective analysis of 302 patients
10    20    1
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: A network meta-analysis

Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: A network meta-analysis
12    27    1
A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma

A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma
9    25    1
Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma

Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma
8    20    1
Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma

Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma
17    18    1
Valuation of the CT LI-RADS treatment response V2018 in patients after first-line deb tace) for hepatocellular carcinoma (HCC)

Valuation of the CT LI-RADS treatment response V2018 in patients after first-line deb tace) for hepatocellular carcinoma (HCC)
8    1    1
Risk thresholds for patients to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinoma: A patient preference study

Risk thresholds for patients to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinoma: A patient preference study
13    1    1
Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation

Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation
14    5    1
CT texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization using random forest models

CT texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization using random forest models
12    2    1
Fragment length profiles of cancer mutations enhance detection of circulating tumor DNA in patients with early-stage hepatocellular carcinoma

Fragment length profiles of cancer mutations enhance detection of circulating tumor DNA in patients with early-stage hepatocellular carcinoma
17    2    1
Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients

Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients
14    7    1
Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint

Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint
11    7    1
Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: Incorporating pre-treatment and post-treatment clinical parameters

Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: Incorporating pre-treatment and post-treatment clinical parameters
15    4    1
Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients

Interferon-induced transmembrane protein 3 in hepatocellular carcinoma patients
7    4    1
Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: A systematic review and meta-analysis

Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: A systematic review and meta-analysis
10    9    1